HEALTHCARE PROFESSIONAL REPORTING - MHRA GUIDE WHAT TO REPORT

Excerpt taken from www.mhra.gov.uk
Reporting
Please complete a Yellow Card if you have a suspicion that a drug has caused an adverse reaction. Do not delay reporting, even if you are in doubt about causality.
Please submit reports for the following:

READ MORE

BLACK TRIANGLE PRODUCT LISTS - MHRA BLACK TRIANGLE DRUGS

Excerpt taken from www.gov.uk
New medicines and vaccines that are under additional monitoring have an inverted black triangle symbol (▼) displayed in their package leaflet and summary of product characteristic, together with a short sentence explaining what the triangle means

READ MORE

UKMi SOP - Yellow Card Submissions via MiDatabank

Yellow Card (YC) reports of suspected adverse drug reactions to the Medicines and Healthcare products Regulatory Agency (MHRA) are an important aspect of pharmacovigilance in the UK. MI pharmacists and technicians frequently come across adverse drug reactions (ADRs) when answering enquiries.

READ MORE

UKMi - ADR Good Practice Guide

Data Protection and confidentiality
Please adhere to data protection principles and avoid typing/copying and pasting any patientidentifiable data into the Adverse Event Description box (freetext box at top of ADR Input screen).N.B. The Yellow Card generated in MiDatabank contains no patient

READ MORE

DRUG ANALYSIS PRINTS (DAPs) - MHRA Drug Analysis Prints

Excerpt taken from www.yellowcard.mhra.gov.uk
The MHRA is pleased to launch interactive Drug Analysis Profiles (iDAPs) on the Yellow Card website. These replace Drug Analysis Prints, which were previously available on the MHRA website. iDAPs are provided for all

READ MORE